U.S. Markets closed

The Medicines Company (MDCO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
39.14-0.25 (-0.63%)
At close: 4:00PM EDT
People also watch
NBIXUTHRNKTRALKSLGND
Interactive chart
Previous Close39.39
Open39.22
Bid0.00 x
Ask0.00 x
Day's Range38.57 - 39.30
52 Week Range30.80 - 55.95
Volume1,332,322
Avg. Volume1,778,347
Market Cap2.82B
Beta0.62
PE Ratio (TTM)-21.29
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Regeneron Presents Positive Phase II Data on HoFH Candidate
    Zacks4 days ago

    Regeneron Presents Positive Phase II Data on HoFH Candidate

    Regeneron Pharmaceuticals, Inc. (REGN) presented positive phase II data, evaluating its investigational angiopoietin-like 3 (ANGPTL3) antibody, evinacumab at the National Lipid Association's (NLA) Scientific Sessions.

  • Capital Cube7 days ago

    ETFs with exposure to The Medicines Co. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to The Medicines Co. Here are 5 ETFs with the largest exposure to MDCO-US. Comparing the performance and risk of The Medicines Co. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • This Fund’s Picks Gained 200% In A Year And Why No One Knows About It
    Insider Monkey13 days ago

    This Fund’s Picks Gained 200% In A Year And Why No One Knows About It

    You probably haven’t heard of Alex Denner‘s Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which its stock picks in companies valued at $1 billion or more delivered weighted average returns of 53.2%, pushing its 1-year returns to an even 200%. With the media paying most of […]